Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Trial to Assess the Efficacy of Long-term (6 Months) Combination Antibiotics as a Treatment for Chlamydia-induced Reactive Arthritis

NCT00351273 is registered in ClinicalTrials.gov with University of South Florida as lead sponsor.

NCT NCT00351273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00351273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Trial to Assess the Efficacy of Long-term (6 Months) Combination Antibiotics as a Treatment for Chlamydia-induced Reactive Arthritis
Lead sponsor
University of South Florida
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2006
Completion date
September 30, 2008
Enrollment
42 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, reactive, reiter disease